This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliver, A. R.
Right arrow Articles by Clark, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliver, A. R.
Right arrow Articles by Clark, D. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2007, p. 3616-3619, Vol. 45, No. 11
0095-1137/07/$08.00+0     doi:10.1128/JCM.00221-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay{triangledown}

Anthony R. Oliver,* Spyridon F. Pereira, and Duncan A. Clark

Diagnostic Virology (Division of Infection), Barts and the London NHS Trust, Pathology & Pharmacy Building, 80 Newark Street, London E1 2ES, United Kingdom

Received 29 January 2007/ Returned for modification 10 June 2007/ Accepted 25 August 2007

The need to evaluate antiviral treatment response and the emergence of resistance have made the human immunodeficiency virus (HIV) viral load assay a major feature of the diagnostic monitoring of HIV-infected individuals. The objective of this study was to evaluate the utility of the recently In Vitro Diagnostic Medical Devices Directive-approved Roche COBAS AmpliPrep/TaqMan96 real-time PCR assay by comparison with the existing Roche COBAS AmpliPrep/AMPLICOR MONITOR conventional PCR assay. EDTA-treated plasma samples from 191 HIV-1-infected individuals were tested for HIV-1 RNA by the AMPLICOR assay and the TaqMan assay. This was a prospective study using 191 pairs of samples from the same bleed per patient. The correlation coefficient of the assays was 98.08%. The mean difference between the assays was 0.05 log10 copy/ml plasma, with a standard deviation (SD) of 0.27 log10 copy/ml plasma. Thirteen samples gave results with variances greater than 0.5 log10 copy/ml plasma, which is our clinical cutoff. Two samples were more than 3 SD different (0.81 log10 copy/ml plasma). The TaqMan assay appeared to be slightly more sensitive at the lower end of the dynamic range. The assays correlated significantly (P > 0.95) with each other, and the regression analysis was also highly significant (R2 > 0.95).

* Corresponding author. Mailing address: Diagnostic Virology (Division of Infection), Barts and the London NHS Trust, Pathology & Pharmacy Building, 80 Newark St., London E1 2ES, United Kingdom. Phone: 44 203 246 0329. Fax: 44 203 246 0325. E-mail: tony.oliver{at}bartsandthelondon.nhs.uk

{triangledown} Published ahead of print on 5 September 2007.

Journal of Clinical Microbiology, November 2007, p. 3616-3619, Vol. 45, No. 11
0095-1137/07/$08.00+0     doi:10.1128/JCM.00221-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Delaugerre, C., Denis, B., Peytavin, G., Palmer, P., Mourez, T., Le Goff, J., Molina, J.-M., Simon, F. (2009). Clinical and Resistance Consequences of Misquantification of Plasma and Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Samples from an HIV-1 Subtype G-Infected Patient. J. Clin. Microbiol. 47: 3763-3764 [Abstract] [Full Text]  
  • Scott, L., Carmona, S., Stevens, W. (2009). Performance of the New Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 Human Immunodeficiency Virus Type 1 Assay. J. Clin. Microbiol. 47: 3400-3402 [Full Text]  
  • Scott, L. E., Noble, L. D., Moloi, J., Erasmus, L., Venter, W. D. F., Stevens, W. (2009). Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays. J. Clin. Microbiol. 47: 2209-2217 [Abstract] [Full Text]  
  • Sloma, C. R., Germer, J. J., Gerads, T. M., Mandrekar, J. N., Mitchell, P. S., Yao, J. D. C. (2009). Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test: Workflow, Reliability, and Direct Costs. J. Clin. Microbiol. 47: 889-895 [Abstract] [Full Text]  
  • Garrido, C., Zahonero, N., Corral, A., Arredondo, M., Soriano, V., de Mendoza, C. (2009). Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests. J. Clin. Microbiol. 47: 1031-1036 [Abstract] [Full Text]  
  • Wei, Y., Yang, C., Wei, B., Huang, J., Wang, L., Meng, S., Zhang, R., Li, J. (2008). RNase-Resistant Virus-Like Particles Containing Long Chimeric RNA Sequences Produced by Two-Plasmid Coexpression System. J. Clin. Microbiol. 46: 1734-1740 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»